{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:37:43Z","timestamp":1779341863348,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.imlet.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T17:15:36Z","timestamp":1530983736000},"page":"15-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Evaluation of SOCS1 methylation in patients with Behcet\u2019s disease"],"prefix":"10.1016","volume":"203","author":[{"given":"Ali","family":"Abdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Khabazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Sakhinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahriar","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Talei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Babaloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2018.07.001_bib0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","article-title":"Efficacy of anti-TNF alpha in severe and\/or refractory Behcet\u2019s disease: multicenter study of 124 patients","volume":"62","author":"Vallet","year":"2015","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.imlet.2018.07.001_bib0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","article-title":"Anti-TNF therapy in the management of Behcet\u2019s disease--review and basis for recommendations","volume":"46","author":"Sfikakis","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.imlet.2018.07.001_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar757","article-title":"Beh\u00e7et\u2019s disease","volume":"5","author":"Hirohata","year":"2003","journal-title":"Arthr. Res. Ther."},{"issue":"5","key":"10.1016\/j.imlet.2018.07.001_bib0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1076\/opep.9.5.325.10338","article-title":"The prevalence of Beh\u00e7et\u2019s disease above the age of 10 years the results of a pilot study conducted at The Park Primary Health Care Center in Ankara, Turkey","volume":"9","author":"Idil","year":"2002","journal-title":"Ophthalmic Epidemiol."},{"issue":"4","key":"10.1016\/j.imlet.2018.07.001_bib0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1258\/095646207780658935","article-title":"Beh\u00e7et\u2019s disease","volume":"18","author":"Yesudian","year":"2007","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.imlet.2018.07.001_bib0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.biopha.2017.04.106","article-title":"Epigenetic alterations in chronic disease focusing on Beh\u00e7et\u2019s disease","volume":"91","author":"Alipour","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.imlet.2018.07.001_bib0035","article-title":"Genetics of Beh\u00e7et\u2019s disease","volume":"2012","author":"Kaya","year":"2011","journal-title":"Pathol. Res. Int."},{"issue":"6","key":"10.1016\/j.imlet.2018.07.001_bib0040","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/art.21060","article-title":"Whole\u2010genome screening for susceptibility genes in multicase families with Beh\u00e7et\u2019s disease","volume":"52","author":"Karasneh","year":"2005","journal-title":"Arthr. Rheum."},{"issue":"35","key":"10.1016\/j.imlet.2018.07.001_bib0045","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1038\/sj.onc.1205609","article-title":"DNA methylation and chromatin-unraveling the tangled web","volume":"21","author":"Robertson","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.imlet.2018.07.001_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12016-009-8166-6","article-title":"Epigenetics in rheumatoid arthritis","volume":"39","author":"Trenkmann","year":"2010","journal-title":"Clin. Rev. Allerg. Immun."},{"issue":"5","key":"10.1016\/j.imlet.2018.07.001_bib0055","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2018.07.001_bib0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/j.gastro.2005.10.051","article-title":"Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFN\u03b3 and IL-4 are involved","volume":"130","author":"Chinen","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.imlet.2018.07.001_bib0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng0501-29","article-title":"SOCS-1, a negative regulator of the JAK\/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity","volume":"28","author":"Yoshikawa","year":"2001","journal-title":"Nat. Genet."},{"issue":"6636","key":"10.1016\/j.imlet.2018.07.001_bib0070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/43213","article-title":"A new protein containing an SH2 domain that inhibits JAK kinases","volume":"387","author":"Endo","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imlet.2018.07.001_bib0075","first-page":"1","article-title":"SOCS1: a potent and multifaceted regulator of cytokines and cell\u2010mediated inflammation","volume":"67","author":"Davey","year":"2006","journal-title":"HLA"},{"key":"10.1016\/j.imlet.2018.07.001_bib0080","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20110428","article-title":"SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-\u03b3 and IL-17A production","author":"Takahashi","year":"2011","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.imlet.2018.07.001_bib0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1521-6616(03)00205-5","article-title":"Methylation and demethylation in the regulation of genes, cells, and responses in the immune system","volume":"109","author":"Fitzpatrick","year":"2003","journal-title":"Clin. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2018.07.001_bib0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/ncpendmet0531","article-title":"Mechanisms of disease: the developmental origins of disease and the role of the epigenotype","volume":"3","author":"Ozanne","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.imlet.2018.07.001_bib0095","article-title":"Molecular analysis of interleukin-10 Gene polymorphisms in patients with Beh\u00e7et\u2019s disease","author":"Afkari","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2018.07.001_bib0100","first-page":"1078","article-title":"International study group for Beh\u00e7et\u2019s disease","volume":"335","author":"CfdoBs","year":"1990","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.imlet.2018.07.001_bib0105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.tig.2007.08.010","article-title":"The potential role of epigenomic dysregulation in complex human disease","volume":"23","author":"Hatchwell","year":"2007","journal-title":"TRENDS Genetics"},{"key":"10.1016\/j.imlet.2018.07.001_bib0110","article-title":"Discordance of DNA methylation variance between two accessible human tissues","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.imlet.2018.07.001_bib0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.imlet.2018.07.001_bib0120","series-title":"Cytokine Imbalance in the Pathogenesis of Rheumatoid Arthritis: the Role of Interleukin-1 Receptor Antagonist. Seminars in Arthritis and Rheumatism","year":"2001"},{"issue":"1","key":"10.1016\/j.imlet.2018.07.001_bib0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.imlet.2018.07.001_bib0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00024382-200202000-00001","article-title":"Suppressors of cytokine signaling (SOCS): inhibitors of the JAK\/STAT pathway","volume":"17","author":"Cooney","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.imlet.2018.07.001_bib0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00020","article-title":"SOCS, inflammation, and autoimmunity","volume":"3","author":"Yoshimura","year":"2012","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2018.07.001_bib0140","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2002-06-1735","article-title":"SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma","volume":"101","author":"Galm","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.imlet.2018.07.001_bib0145","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ijc.20521","article-title":"Epigenetic inactivation of SOCS\u20101 by CpG island hypermethylation in human gastric carcinoma","volume":"112","author":"Oshimo","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.imlet.2018.07.001_bib0150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/sji.12211","article-title":"Differential expression of suppressor of cytokine signalling proteins in Beh\u00e7et\u2019s disease","volume":"80","author":"Hamedi","year":"2014","journal-title":"Scand. J. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247818301676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247818301676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T22:31:38Z","timestamp":1543617098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247818301676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":30,"alternative-id":["S0165247818301676"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2018.07.001","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of SOCS1 methylation in patients with Behcet\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}